Financial Specialist I - STS, GFS APAC at Gilead Sciences

Singapore, Singapore, Singapore

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

At least 3 years of relevant working experience (experience in financial shared services is preferable)
Accounting / Finance / Business degree is preferable
ACA/ACCA/CPA qualification is preferred
Good understanding of accounting principles and practices
Experience in interacting with external and internal auditors along with detailed knowledge and experience of SOX Compliance is preferred
Working knowledge and experience of SAP or similar ERP product is preferred
Proficiency with Microsoft tools (Excel, Outlook, and Word) required
Fluency in Mandarin to liaise with counterparts in Mandarin speaking markets
Self-starter and able to act on own initiative
Self-driven with high levels of integrity, excellence and teamwork
Excellent problem-solving skills and ability to be detail oriented
Capable of managing multiple priorities simultaneously, working under pressure and to meet strict reporting deadlines
Excellent communication and interpersonal skills (oral, written, presentational)
Demonstrates teamwork and collaborative approach to work
Ability to travel to Asia as required

Responsibilities

Able to handle STS & OTC processes in a professional manner; ability to follow up and resolve outstanding items and exceptions in a timely basis
Contribution to the definition of service standards and continuous management of service level agreements with internal stakeholders and external vendors
Contribution to the definition and maintenance of key performance indicators (KPIs) and the establishment of a continuous improvement culture
Responsible for the timely preparation of the month end closing procedures for APAC market in high quality (or other markets per business needs)
Ensure financial records are in compliance with GAAP
Consistently maintains appropriate internal controls and upholds company policies & procedures including Worldwide Controller’s manual
Interacts successfully with internal and external auditors by providing timely & accurate data and communication
Evaluates processes and recommends & implements process improvements
Helps develop, maintain and assess internal controls related to Gilead’s accounting and financial reporting systems
Interacts successfully with non-financial personnel; ensure proper training and development objectives are met
Any ad hoc tasks as assigned

Skills

STS

OTC

GAAP

Month End Closing

KPIs

Service Level Agreements

Internal Controls

Financial Records

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free